Jan Hillert, MD, PhD, professor and senior physician in the department of clinical neuroscience, Karolinska Institutet, Stockholm, Sweden, discusses the body of knowledge on using stem cell transplants to treat patients with multiple sclerosis (MS).
Jan Hillert, MD, PhD, professor and senior physician in the department of clinical neuroscience, Karolinska Institutet, Stockholm, Sweden, discusses the body of knowledge on using stem cell transplants to treat patients with multiple sclerosis (MS).
Transcript
What is the current state of knowledge about using stem cell transplants in patients with MS?
There is an increasing body of evidence indicating that the effectiveness of such procedures is very good. The proportion of patients having gone through such a procedure having no evidence of disease activity, what we can NEDA, is unparalleled by other ways of treating MS. So for sure, this is a very efficient way of stopping the relapsing form of MS.
Whether it also prevents the progressive phase, which comes long after, we don’t know yet. We know that if we do the transplants when the patient is already in the progressive phase, then the progression carries on, so we need to do it early.
The remaining issue which prevents this from being very, very widespread is of course the safety side. It looks really promising. In some of the regiments, some of the ways in which to do this, there have been very few side effects and practically no mortality. Whereas in some of the other ways of doing it, there are still people dying from the procedure itself. So we need to ensure, of course, if we launch this as a treatment for a big proportion of MS patients, that it’s really safe.
Then the question ethically becomes, what kind of mortality can we accept? It needs to be way below a percent, of course. So that’s why there is still hesitation, I would say. But the efficacy or effectiveness evidence, they look just fantastic.
Dr Kathryn Lindley on Pregnancy-Related Cardiovascular Care Gaps and Training Initiatives
December 8th 2023Cardiologists need skills in risk assessment, contraception counseling, and hypertension management for pregnant patients, according to Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center.
Read More
Dr Kathryn Lindley Explains the Importance of Cardio-Obstetrics in Fellowship Programs
December 5th 2023Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center, talks about why it’s important to incorporate cardio-obstetrics training into cardiovascular disease fellowship programs.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Patient-Reported Outcomes Reinforce Efficacy of Natalizumab for MS
November 21st 2023Researchers gathered data on patient-reported outcomes to support evidence for the continuation of natalizumab, a disease-modifying treatment, in the management of multiple sclerosis (MS) progression.
Read More
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More